Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

September 15, 2009; 73 (11) Clinical Implications of Neuroscience Research

Serotonergic modulation of basal ganglia circuits

Complexity and therapeutic opportunities

Eduardo E. Benarroch
First published September 14, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181b784e7
Eduardo E. Benarroch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Serotonergic modulation of basal ganglia circuits
Complexity and therapeutic opportunities
Eduardo E. Benarroch
Neurology Sep 2009, 73 (11) 880-886; DOI: 10.1212/WNL.0b013e3181b784e7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
538

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Glossary

DA=
dopamine;
DRN=
dorsal raphe nucleus;
GABA=
γ-aminobutyric acid;
5-HT=
5-hydroxytryptamine;
l-DOPA, levodopa=
l-dihydroxyphenylalanine;
MPTP=
1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine;
6-OHDA=
6-hydroxydopamine;
PD=
Parkinson disease;
SERT=
serotonin transporter;
SNc=
substantia nigra pars compacta;
SNr=
substantia nigra pars reticulata;
VTA=
ventral tegmental area.

GLOSSARY

Serotonergic innervation of the CNS originates from the raphe nuclei and exerts widespread influence on behavior. Serotonin (5-hydroxytryptamine, 5-HT) has an important neuromodulatory action that is mediated by a large variety of 5-HT receptor subtypes. The central serotonergic system has been implicated in mechanisms of cognition, emotion, impulse control, circadian and sleep-wake cycle regulation, pain modulation, and respiratory, cardiovascular, and motor functions. Experimental studies have provided a large amount of information on the multiple effects of 5-HT on the basal ganglia circuits at the levels of the prefrontal cortex, striatum, globus pallidus, and subthalamic nucleus, both directly and via 5-HT interactions with the dopaminergic system. Both the serotonergic and dopaminergic systems are affected in neurodegenerative disorders such as Parkinson disease (PD) and Alzheimer disease and have been implicated in the pathophysiology of depression, obsessive compulsive disorder, drug addiction, schizophrenia, and other disorders. The complex interactions between the serotonergic and dopaminergic systems at the levels of the basal ganglia and cerebral cortex, and their implications for PD and several psychiatric disorders, have been comprehensively reviewed.1–6 Some general concepts and potential clinical implications for PD are emphasized here.

ANATOMY, NEUROCHEMISTRY, AND PHYSIOLOGY OF THE RAPHE SEROTONERGIC SYSTEM

Anatomy.

The raphe nuclei are located in the midline throughout the brainstem and are subdivided into a rostral and a caudal group.6 The rostral raphe nuclei include the dorsal raphe nucleus (DRN) and median raphe nucleus, which provide inputs to the forebrain and upper brainstem; the caudal raphe nuclei provide inputs to the lower brainstem and spinal cord. The DRN provides the major serotonergic input to basal ganglia circuits, including the dopaminergic neurons of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) and all their targets, including the striatum, globus pallidus, substantia nigra pars reticulata (SNr), subthalamic nucleus, and prefrontal cortex (figure 1).3–6 At all these levels, serotonergic …

View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Glossary
    • GLOSSARY
    • ANATOMY, NEUROCHEMISTRY, AND PHYSIOLOGY OF THE RAPHE SEROTONERGIC SYSTEM
    • SEROTONERGIC MODULATION OF THE BASAL GANGLIA CIRCUITS
    • POTENTIAL IMPLICATION FOR PD
    • PERSPECTIVE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (8)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise